Emilyn Banfield Selected Research

6'-sialyllactose

1/2021	The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling.
1/2021	Insights image for "The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling."

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emilyn Banfield Research Topics

Disease

2	Necrotizing Enterocolitis 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2017 - 10/2016
1	Weight Loss (Weight Reduction) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020
1	Ulcerative Colitis 10/2020
1	Heart Diseases (Heart Disease) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017

Drug/Important Bio-Agent (IBA)

2	2'-fucosyllactoseIBA 01/2021 - 01/2021
2	6'-sialyllactoseIBA 01/2021 - 01/2021
2	OligosaccharidesIBA 01/2021 - 01/2021
2	Toll-Like Receptor 4IBA 01/2021 - 01/2021
1	SugarsIBA 01/2021
1	Lactose FDA LinkGeneric 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	EndotoxinsIBA 10/2020
1	LipopolysaccharidesIBA 10/2020
1	Dextran SulfateIBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2016